{{Rsnum
|rsid=3118470
|Gene=IL2RA
|Chromosome=10
|position=6101713
|Orientation=plus
|GMAF=0.3186
|Assembly=GRCh37
|GenomeBuild=37.1
|dbSNPBuild=131
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}
{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 10.6 | 40.7 | 48.7
| HCB | 27.0 | 51.1 | 21.9
| JPT | 20.5 | 45.5 | 33.9
| YRI | 0.0 | 19.7 | 80.3
| ASW | 0.0 | 24.6 | 75.4
| CHB | 27.0 | 51.1 | 21.9
| CHD | 19.3 | 52.3 | 28.4
| GIH | 17.8 | 48.5 | 33.7
| LWK | 2.7 | 28.2 | 69.1
| MEX | 1.7 | 39.7 | 58.6
| MKK | 3.8 | 24.4 | 71.8
| TSI | 2.0 | 39.2 | 58.8
| HapMapRevision=28
}}

{{Report GE
|PubMed=17395754
|Source=17676041
|AffyProbeset=SNP_A-8598463
|AffyOrientation=reverse
|AlleleA=A
|AlleleB=G
|onGW5=0
|rsid=3118470
|ancestral=T
|RiskPopulation=
|RiskAllele=C
|CaseFreq=
|ControlFreq=
|OddsRatioHet=
|OddsRatioHom=
|OddsRatioAll=1.28
|Disease=Type I Diabetes
|DiseaseSymbol=T1D
}}

{{ neighbor
| rsid = 12722489
| distance = 299
}}

rs3118470 increases susceptibility to Type I Diabetes 1.28 times for carriers of the C allele {{PMID|17395754}}

{{PMID Auto
|PMID=19794070
|Title=A cis-Acting Regulatory Variant in the IL2RA Locus
}}

{{PMID Auto
|PMID=19956099
|Title=The type I diabetes association of the IL2RA locus
|OA=1
}}

{{PMID Auto
|PMID=20615141
|Title=Association of the Protein Tyrosine Phosphatase Nonreceptor 22 Haplotypes with Autoimmune Thyroid Disease in the Japanese Population
}}
{{PMID Auto GWAS
|PMID=20596022
|Trait=Alopecia areata
|Title=Genome-wide association study in alopecia areata implicates both innate and adaptive immunity
|RiskAllele=G
|Pval=2E-12
|OR=1.41
|ORtxt=[1.27-1.56]
|OA=1
}}

{{PMID Auto
|PMID=22085902
|Title=Determination of the real effect of genes identified in GWAS: the example of IL2RA in multiple sclerosis
|OA=1
}}

{{PMID Auto
|PMID=22211793
|Title=Polymorphic variants of the IL2RA gene and susceptibility to type 1 diabetes in the Polish population.
}}

{{PMID|18556337|OA=1
}} Impact of diabetes susceptibility loci on progression from pre-diabetes to diabetes in at-risk individuals of the diabetes prevention trial-type 1 (DPT-1).

{{PMID|18776148|OA=1
}} Joint genetic susceptibility to type 1 diabetes and autoimmune thyroiditis: from epidemiology to mechanisms.

{{PMID|18840781|OA=1
}} Follow-up analysis of genome-wide association data identifies novel loci for type 1 diabetes.

{{PMID|19106270}} Genetic association between the interleukin-2 receptor-alpha gene and mode of onset of type 1 diabetes in the Japanese population.

{{PMID|19956101|OA=1
}} Overview of the Rapid Response data.

{{PMID|19956106|OA=1
}} Analysis of 19 genes for association with type I diabetes in the Type I Diabetes Genetics Consortium families.

{{PMID Auto GWAS
  |PMID=21833088
  |Trait=Multiple sclerosis
  |Title=Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis.
  |RiskAllele=G
  |Pval=3E-11
  |OR=1.12
  |ORtxt=[1.1-1.13]
  |OA=1
}}

{{PMID Auto
|PMID=22213266
|Title=Functional polymorphism rs7072793 C > T affect individual susceptibility to breast cancer by modulating CD25 transcription activity.
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}